Hereditary [regulatory (CFH, CFI, or CD46) or effector (complement factor B or C3) gene mutations] or primary acquired (antibodies against factor H) complement-mediated TMA is due to the uncontrolled activation of the alternative pathway of the complement resulting in acute kidney injury and hypertension. The gene discussed is CFH; the disease is acute kidney injury.